SCHEMBL6164219

SCHEMBL6164219

O=Cc1cccc(-c2cnsn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 1/20 0.44
DYRK1A Q13627 3/20 0.42
DYRK2 Q92630 3/20 0.42
DYRK1B Q9Y463 3/20 0.42
DYRK3 O43781 2/20 0.42
CCNT1 O60563 2/20 0.42
CDK9 P50750 2/20 0.42
CDK5 Q00535 2/20 0.42
CDK5R1 Q15078 2/20 0.42
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
BRD4 O60885 1/20 0.41
AXL P30530 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 3/20 0.39
UNG P13051 1/20 0.36
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31327369 0.77 CDK8 (0.58) CDK8DYRK1ADYRK2DYRK1BDYRK3
SCHEMBL2728342 0.75 IDO1 (0.51) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL707146 0.75 NPC1 (0.47) ALDH1A1KDM4EMEN1NPC1KMT2A
SCHEMBL346974 0.73 TRIM24 (0.64) CDK8DYRK1ADYRK2DYRK1BDYRK3
SCHEMBL708223 0.73 TLR4 (0.42) ALDH1A1MEN1NPC1POLBKMT2A
SCHEMBL27621710 0.71 TRIM24 (0.68) CDK8DYRK1ADYRK2DYRK1BDYRK3
SCHEMBL30541407 0.70 PIM2 (0.65) CDK8DYRK1ADYRK2DYRK1BDYRK3
SCHEMBL4529365 0.70 DYRK1A (0.45) CDK8DYRK1ADYRK2DYRK1BDYRK3
SCHEMBL5727823 0.70 DYRK1A (0.49) DYRK1AALDH1A1NPC1CYP2A6
SCHEMBL29569630 0.70 DYRK1A (0.45) CDK8DYRK1ADYRK2DYRK1BDYRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106608859-A Synthetic method of 1,2,5-thiazolinone-1,1-dioxide and 2,3-dihydro-1,2,5-thiadiazole-1,1-dioxide containing quaternary carbon chiral centers 中国科学院上海药物研究所 2017-05-03 CN disclosed
EP-1254133-B9 INDOL-3-YL DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS MERCK PATENT GMBH (DE) 2005-09-07 EP disclosed
EP-1254133-B1 INDOL-3-YL DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS MERCK PATENT GMBH (DE) 2005-04-20 EP disclosed
EP-1254133-A2 INDOL-3-YL DERIVATIVES MERCK PATENT GmbH (DE) 2002-11-06 EP disclosed
WO-2001058893-A2 INDOL-3-YL DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS MERCK PATENT GMBH (DE) 2001-08-16 WO disclosed